CY-1899

UNII:	HM7AT2E2B6
Type:	INGREDIENT SUBSTANCE
Formula:
Preferred Substance Name:	CY-1899
GSRS Full Record:	HM7AT2E2B6 i

186511-30-8
CY 1899 [WHO-DD]
CY1899
IMMUNOTHERAPEUTIC VACCINE CONSISTING OF (PAM)2-LYS-SER-SER-GLN-TYR-ILE-LYS-ALA-ASN-SER-LYS-PHE-ILE-GLY-ILE-THR-GLU-ALA-ALA-ALA-PHE-LEU-PRO-SER-ASP-PHE-PHE-PRO-SER-VAL
L-Valine, N2,N6-bis(1-oxohexadecyl)-L-lysyl-L-seryl-L-seryl-L-glutaminyl-L-tyrosyl-L-isoleucyl-L-lysyl-L-alanyl-L-asparaginyl-L-seryl-L-lysyl-L-phenylalanyl-L-isoleucylglycyl-L-isoleucyl-L-threonyl-L-α-glutamyl-L-alanyl-L-alanyl-L-alanyl-L-phenylalanyl-L-leucyl-L-prolyl-L-seryl-L-α-aspartyl-L-phenylalanyl-L-phenylalanyl-L-prolyl-L-seryl-
THERADIGM HBV

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

CY-1899

Synonyms and Mappings

Resources